Mirati Therapeutics Inc.

NASDAQ: MRTX · Real-Time Price · USD
58.70
-0.10 (-0.17%)
At close: Jan 22, 2024, 10:00 PM

Mirati Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
235.26M 413.08M
Short-Term Investments
848.58M 1.08B
Long-Term Investments
3.46M 8.22M
Other Long-Term Assets
21.64M 19.05M
Receivables
865K n/a
Inventory
3.02M -2.51M
Other Current Assets
21.24M 16.64M
Total Current Assets
1.11B 1.51B
Property-Plant & Equipment
53.66M 53.5M
Goodwill & Intangibles
14.91M n/a
Total Long-Term Assets
93.69M 80.77M
Total Assets
1.2B 1.59B
Account Payables
38.86M 35.16M
Deferred Revenue
n/a -1.34M
Short-Term Debt
7.84M n/a
Other Current Liabilities
112.74M 108.5M
Total Current Liabilities
159.45M 143.66M
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
46.68M 48.06M
Total Long-Term Liabilities
46.68M 48.06M
Total Liabilities
206.13M 191.72M
Total Debt
51.51M 45.88M
Common Stock
58K 55K
Retained Earnings
-2.45B -1.71B
Comprehensive Income
-3.72M 9.07M
Shareholders Equity
996.52M 1.4B
Total Investments
848.58M 1.09B